Arcutis Biotherapeutics (ARQT) Revenue & Revenue Breakdown
Arcutis Biotherapeutics Revenue Highlights
Latest Revenue (Y)
$59.61M
Latest Revenue (Q)
$30.86M
Main Segment (Y)
Other Revenue
Arcutis Biotherapeutics Revenue by Period
Arcutis Biotherapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $59.61M | 1517.09% |
| 2022-12-31 | $3.69M | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | - |
Arcutis Biotherapeutics generated $59.61M in revenue during NA 2023, up 1517.09% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Arcutis Biotherapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $30.86M | -37.75% |
| 2024-03-31 | $49.57M | 266.47% |
| 2023-12-31 | $13.53M | -64.51% |
| 2023-09-30 | $38.11M | 634.28% |
| 2023-06-30 | $5.19M | 86.62% |
| 2023-03-31 | $2.78M | -6.08% |
| 2022-12-31 | $2.96M | 308.41% |
| 2022-09-30 | $725.00K | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | - |
Arcutis Biotherapeutics generated $30.86M in revenue during Q2 2024, up -37.75% compared to the previous quarter, and up 1109.60% compared to the same period a year ago.
Arcutis Biotherapeutics Revenue Breakdown
Arcutis Biotherapeutics Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 |
|---|---|---|
| Other Revenue | $30.42M | - |
| Product | $29.19M | $3.69M |
Arcutis Biotherapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 23: Other Revenue (51.04%), and Product (48.96%).
Quarterly Revenue by Product
| Product/Service | Dec 23 | Sep 23 | Dec 22 | Sep 22 |
|---|---|---|---|---|
| Product | $21.08M | $8.11M | $2.96M | $725.00K |
| Other Revenue | $420.00K | $30.00M | - | - |
Arcutis Biotherapeutics's latest quarterly revenue breakdown by segment (product or service), as of Dec 23: Product (98.05%), and Other Revenue (1.95%).
Arcutis Biotherapeutics Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Dec 22 | Sep 22 |
|---|---|---|
| Product | $2.96M | $725.00K |
Arcutis Biotherapeutics's latest quarterly revenue breakdown by geography, as of Dec 22: Product (100.00%).
Arcutis Biotherapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| AMLX | Amylyx Pharmaceuticals | $380.79M | $88.64M |
| APLS | Apellis Pharmaceuticals | $366.28M | $179.14M |
| CHRS | Coherus BioSciences | $257.24M | $64.98M |
| MIRM | Mirum Pharmaceuticals | $186.37M | $69.22M |
| SPRO | Spero Therapeutics | $96.73M | $10.20M |
| ARQT | Arcutis Biotherapeutics | $59.61M | $30.86M |
| VECT | VectivBio | $27.34M | $676.00K |
| BOLT | Bolt Biotherapeutics | $7.88M | $1.27M |
| DSGN | Design Therapeutics | - | - |
| XFOR | X4 Pharmaceuticals | - | $563.00K |
| GRCL | Gracell Bio | - | - |
| DAWN | Day One Biopharmaceuticals | - | $20.07M |
| ABOS | Acumen Pharmaceuticals | - | - |
| INZY | Inozyme Pharma | - | - |
| ERAS | Erasca | - | - |
| NLTX | Neurogene | - | - |
| TERN | Terns Pharmaceuticals | - | - |
| GLUE | Monte Rosa Therapeutics | - | $4.70M |
ARQT Revenue FAQ
What is Arcutis Biotherapeutics’s yearly revenue?
Arcutis Biotherapeutics's yearly revenue for 2023 was $59.61M, representing an increase of 1517.09% compared to 2022. The company's yearly revenue for 2022 was $3.69M, representing an increase of 100.00% compared to 2021. ARQT's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is Arcutis Biotherapeutics’s quarterly revenue?
Arcutis Biotherapeutics's quarterly revenue for Q2 2024 was $30.86M, a -37.75% decrease from the previous quarter (Q1 2024), and a 494.57% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $49.57M, a 266.47% increase from the previous quarter (Q4 2023), and a 1682.42% increase year-over-year (Q1 2023). ARQT's quarterly revenue for Q4 2023 was $13.53M, a -64.51% decrease from the previous quarter (Q3 2023), and a 356.81% increase year-over-year (Q4 2022).
What is Arcutis Biotherapeutics’s revenue growth rate?
Arcutis Biotherapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.
What are Arcutis Biotherapeutics’s revenue streams?
Arcutis Biotherapeutics's revenue streams in c 23 are Other Revenue, and Product. Other Revenue generated $30.42M in revenue, accounting 51.04% of the company's total revenue Product generated $29.19M in revenue, accounting 48.96% of the company's total revenue, up 691.81% year-over-year.
What is Arcutis Biotherapeutics’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Arcutis Biotherapeutics was Other Revenue. This segment made a revenue of $30.42M, representing 51.04% of the company's total revenue.